US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

NanoViricides, Inc. Common Stock (NY:NNVC)

1.450 +0.170 (+13.28%)
Official Closing Price Updated: 6:30 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about NanoViricides, Inc. Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
News headline image
Nanomedicine Company Makes "Nanomachines" that Attack Viruses ↗
Photo by Fusion Medical Animation on Unsplash Ever since scientists discovered the existence of viruses in the late 1800s, virologists have tried to understand and prevent them... 
Via Benzinga
News headline image
NanoViricides Review: What you Need to Know About the Company ↗
With the coronavirus changing the world in 2020, it makes sense that there’s a spotlight on science to prevent viruses from growing into pandemics. While Pfizer (NYSE: PFE)... 
Via Benzinga
News headline image
NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards IND
SHELTON, CT / ACCESSWIRE / May 17, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel... 
From NanoViricides, Inc.
Via AccessWire
Topics Regulatory Compliance
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >